AC Immune is a leading Swiss-based biopharmaceutical company with three products in clinical trials for the treatment of Alzheimer's disease. AC Immune designs, discovers and develops therapeutic and diagnostic products to prevent and modify diseases caused by misfolding proteins.
Domain: Therapeutics & Diagnostics
Therapeutics & Diagnostics, Antibodies / Anti-infectives
Therapeutics & Diagnostics, Chemical Drug, small Molecules
Therapeutics & Diagnostics, Molecular Diagnostic
Therapeutics & Diagnostics, Vaccines
Contact: EPFL Innovation Park, Bât. B
1015 Lausanne / VD
P: 021 345 91 21

http://www.acimmune.com
Find an actor

Journée de l'Innovation 2017 aux HUG Jeudi 19 octobre19.10.2017

11ème Journée de l’innovation au Centre de l’innovation des HUG. Conférences, concours de pitchs, remise des...

Pryv SA closes 1.1M CHF Pre-Series A to accelerate growth and prepare Series A funding round

Pryv SA, an independent Swiss Health-IT company, specialized in providing innovative data management and digital...
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn